{"id":"https://openalex.org/W2307183330","doi":"https://doi.org/10.1586/14779072.2016.1167598","title":"Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension","display_name":"Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension","publication_year":2016,"publication_date":"2016-03-17","ids":{"openalex":"https://openalex.org/W2307183330","doi":"https://doi.org/10.1586/14779072.2016.1167598","mag":"2307183330","pmid":"https://pubmed.ncbi.nlm.nih.gov/26986445"},"language":"en","primary_location":{"id":"doi:10.1586/14779072.2016.1167598","doi":"https://doi.org/10.1586/14779072.2016.1167598","is_oa":false,"landing_page_url":"https://doi.org/10.1586/14779072.2016.1167598","pdf_url":null,"source":{"id":"https://openalex.org/S108504264","display_name":"Expert Review of Cardiovascular Therapy","issn_l":"1477-9072","issn":["1477-9072","1744-8344"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Cardiovascular Therapy","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082798711","display_name":"Gary E. Sander","orcid":"https://orcid.org/0000-0001-7307-4092","observed_orcids":["https://orcid.org/0000-0001-7307-4092"]},"institutions":[{"id":"https://openalex.org/I114832834","display_name":"Tulane University","ror":"https://ror.org/04vmvtb21","country_code":"US","type":"education","lineage":["https://openalex.org/I114832834"]},{"id":"https://openalex.org/I2800269015","display_name":"Tulane Medical Center","ror":"https://ror.org/031w3f751","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800269015"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary E. Sander","raw_affiliation_strings":["a Heart & Vascular Institute, Department of Medicine , Tulane University Medical Center , New Orleans , LA , USA","Heart & Vascular Institute, Department of Medicine, Tulane University Medical Center, New Orleans, LA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a Heart & Vascular Institute, Department of Medicine , Tulane University Medical Center , New Orleans , LA , USA","institution_ids":["https://openalex.org/I114832834","https://openalex.org/I2800269015"]},{"raw_affiliation_string":"Heart & Vascular Institute, Department of Medicine, Tulane University Medical Center, New Orleans, LA, USA","institution_ids":["https://openalex.org/I114832834","https://openalex.org/I2800269015"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087350603","display_name":"Camilo Fernandez","orcid":"https://orcid.org/0000-0002-1828-2419","observed_orcids":["https://orcid.org/0000-0002-1828-2419"]},"institutions":[{"id":"https://openalex.org/I114832834","display_name":"Tulane University","ror":"https://ror.org/04vmvtb21","country_code":"US","type":"education","lineage":["https://openalex.org/I114832834"]},{"id":"https://openalex.org/I2800269015","display_name":"Tulane Medical Center","ror":"https://ror.org/031w3f751","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800269015"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Camilo Fernandez","raw_affiliation_strings":["a Heart & Vascular Institute, Department of Medicine , Tulane University Medical Center , New Orleans , LA , USA","Heart & Vascular Institute, Department of Medicine, Tulane University Medical Center, New Orleans, LA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a Heart & Vascular Institute, Department of Medicine , Tulane University Medical Center , New Orleans , LA , USA","institution_ids":["https://openalex.org/I114832834","https://openalex.org/I2800269015"]},{"raw_affiliation_string":"Heart & Vascular Institute, Department of Medicine, Tulane University Medical Center, New Orleans, LA, USA","institution_ids":["https://openalex.org/I114832834","https://openalex.org/I2800269015"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046628178","display_name":"Thomas D. Giles","orcid":"https://orcid.org/0000-0002-0476-7108","observed_orcids":["https://orcid.org/0000-0002-0476-7108"]},"institutions":[{"id":"https://openalex.org/I114832834","display_name":"Tulane University","ror":"https://ror.org/04vmvtb21","country_code":"US","type":"education","lineage":["https://openalex.org/I114832834"]},{"id":"https://openalex.org/I2800269015","display_name":"Tulane Medical Center","ror":"https://ror.org/031w3f751","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800269015"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Thomas D. Giles","raw_affiliation_strings":["a Heart & Vascular Institute, Department of Medicine , Tulane University Medical Center , New Orleans , LA , USA","Heart & Vascular Institute, Department of Medicine, Tulane University Medical Center, New Orleans, LA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a Heart & Vascular Institute, Department of Medicine , Tulane University Medical Center , New Orleans , LA , USA","institution_ids":["https://openalex.org/I114832834","https://openalex.org/I2800269015"]},{"raw_affiliation_string":"Heart & Vascular Institute, Department of Medicine, Tulane University Medical Center, New Orleans, LA, USA","institution_ids":["https://openalex.org/I114832834","https://openalex.org/I2800269015"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5046628178"],"corresponding_institution_ids":["https://openalex.org/I114832834","https://openalex.org/I2800269015"],"apc_list":null,"apc_paid":null,"fwci":0.1593,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.18175504,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"14","issue":"5","first_page":"563","last_page":"572"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nebivolol","display_name":"nebivolol","score":0.9879999756813049},{"id":"https://openalex.org/keywords/valsartan","display_name":"valsartan","score":1.0},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.925000011920929},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.9359999895095825},{"id":"https://openalex.org/keywords/blood-pressure-targets","display_name":"blood pressure targets","score":0.6100000143051147},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.6639999747276306},{"id":"https://openalex.org/keywords/renin-angiotensin-aldosterone-system-inhibitors","display_name":"renin-angiotensin-aldosterone system inhibitors","score":0.9409999847412109},{"id":"https://openalex.org/keywords/vasodilation","display_name":"vasodilation","score":0.7509999871253967},{"id":"https://openalex.org/keywords/plasma-renin-activity","display_name":"plasma renin activity","score":0.9129999876022339},{"id":"https://openalex.org/keywords/plasma-aldosterone-concentration","display_name":"plasma aldosterone","score":0.8730000257492065},{"id":"https://openalex.org/keywords/ambulatory-blood-pressure-monitoring","display_name":"ambulatory blood pressure monitoring","score":0.9319999814033508},{"id":"https://openalex.org/keywords/antihypertensive-therapy","display_name":"antihypertensive therapy","score":0.7979999780654907}],"concepts":[{"id":"https://openalex.org/C2777537511","wikidata":"https://www.wikidata.org/wiki/Q418130","display_name":"Nebivolol","level":3,"score":0.9433907270431519},{"id":"https://openalex.org/C2777387769","wikidata":"https://www.wikidata.org/wiki/Q155472","display_name":"Valsartan","level":3,"score":0.9079247713088989},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8959804177284241},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7100411653518677},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.6733976602554321},{"id":"https://openalex.org/C2778525890","wikidata":"https://www.wikidata.org/wiki/Q184564","display_name":"Aldosterone","level":2,"score":0.5650627613067627},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5433855652809143},{"id":"https://openalex.org/C2777097880","wikidata":"https://www.wikidata.org/wiki/Q988405","display_name":"Essential hypertension","level":3,"score":0.4913574755191803},{"id":"https://openalex.org/C120770815","wikidata":"https://www.wikidata.org/wiki/Q14859627","display_name":"Vasodilation","level":2,"score":0.4529321789741516},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4483986794948578},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4255572259426117},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3887535333633423},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.13072726130485535}],"mesh":[{"descriptor_ui":"D000068577","descriptor_name":"Nebivolol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068756","descriptor_name":"Valsartan","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1586/14779072.2016.1167598","doi":"https://doi.org/10.1586/14779072.2016.1167598","is_oa":false,"landing_page_url":"https://doi.org/10.1586/14779072.2016.1167598","pdf_url":null,"source":{"id":"https://openalex.org/S108504264","display_name":"Expert Review of Cardiovascular Therapy","issn_l":"1477-9072","issn":["1477-9072","1744-8344"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Cardiovascular Therapy","raw_type":"journal-article"},{"id":"pmid:26986445","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26986445","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of cardiovascular therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":75,"referenced_works":["https://openalex.org/W180942899","https://openalex.org/W1518281645","https://openalex.org/W1966494514","https://openalex.org/W1973163598","https://openalex.org/W1978190600","https://openalex.org/W1983500350","https://openalex.org/W1993604124","https://openalex.org/W1996041945","https://openalex.org/W1996101611","https://openalex.org/W1996667713","https://openalex.org/W1997023449","https://openalex.org/W1997771891","https://openalex.org/W1998899450","https://openalex.org/W2001341183","https://openalex.org/W2003670762","https://openalex.org/W2006851144","https://openalex.org/W2010799694","https://openalex.org/W2017578479","https://openalex.org/W2018076136","https://openalex.org/W2023140063","https://openalex.org/W2025148534","https://openalex.org/W2025503691","https://openalex.org/W2033259921","https://openalex.org/W2036794681","https://openalex.org/W2051631702","https://openalex.org/W2056976690","https://openalex.org/W2065721205","https://openalex.org/W2065726373","https://openalex.org/W2069381423","https://openalex.org/W2077711974","https://openalex.org/W2077742145","https://openalex.org/W2082402917","https://openalex.org/W2085212344","https://openalex.org/W2094326208","https://openalex.org/W2094872624","https://openalex.org/W2102842180","https://openalex.org/W2103047096","https://openalex.org/W2105095326","https://openalex.org/W2108151521","https://openalex.org/W2109585772","https://openalex.org/W2110882681","https://openalex.org/W2114369401","https://openalex.org/W2116462976","https://openalex.org/W2118286022","https://openalex.org/W2120314099","https://openalex.org/W2125440793","https://openalex.org/W2126125759","https://openalex.org/W2132151006","https://openalex.org/W2133416234","https://openalex.org/W2135708566","https://openalex.org/W2138377901","https://openalex.org/W2140446943","https://openalex.org/W2143734447","https://openalex.org/W2146069684","https://openalex.org/W2146190354","https://openalex.org/W2147279241","https://openalex.org/W2152228398","https://openalex.org/W2152660527","https://openalex.org/W2154831591","https://openalex.org/W2156121263","https://openalex.org/W2166383881","https://openalex.org/W2167003284","https://openalex.org/W2167557672","https://openalex.org/W2167760816","https://openalex.org/W2168553362","https://openalex.org/W2168907840","https://openalex.org/W2169354842","https://openalex.org/W2169731574","https://openalex.org/W2176314335","https://openalex.org/W2181350280","https://openalex.org/W2198866495","https://openalex.org/W2312351061","https://openalex.org/W2427094903","https://openalex.org/W3021250193","https://openalex.org/W3150595609"],"related_works":["https://openalex.org/W2595587954","https://openalex.org/W2614506045","https://openalex.org/W2069655935","https://openalex.org/W2901433517","https://openalex.org/W2026189590","https://openalex.org/W2116462976","https://openalex.org/W2608474888","https://openalex.org/W2025503691","https://openalex.org/W2059987467","https://openalex.org/W2910964108"],"abstract_inverted_index":{"Recent":[0],"large":[1],"clinical":[2,103],"trials":[3],"have":[4,88],"refuted":[5],"earlier":[6],"suggestions":[7],"from":[8,177,225],"the":[9,125,166,183,195,214,232],"Joint":[10],"National":[11],"Committee":[12],"8":[13],"committee":[14],"that":[15,25,37,141,178,182,194,218],"less":[16],"aggressive":[17],"targets":[18,46],"for":[19,52],"blood":[20,44,72,163],"pressure":[21,45,73,164],"control":[22],"were":[23,158],"all":[24],"could":[26],"be":[27],"justified":[28],"in":[29,38,134,161,189],"most":[30],"hypertensive":[31,54],"patients.":[32,55],"It":[33],"now":[34],"does":[35],"appear":[36],"fact":[39],"\"lower":[40],"is":[41,75,107],"better,\"":[42],"with":[43,136,169],"<":[47],"120/80":[48],"mm":[49,68],"Hg":[50,69],"appropriate":[51],"many":[53],"Two":[56],"drug":[57],"combinations":[58,145],"are":[59],"often":[60],"indicated":[61],"as":[62],"initial":[63],"therapy":[64],"if":[65],"a":[66,108,186],"20/10":[67],"or":[70],"greater":[71],"reduction":[74],"necessary":[76],"to":[77],"reach":[78],"target.":[79],"Combinations":[80],"consisting":[81],"of":[82,99,147,216,235],"\u03b2-blockers":[83],"and":[84,101,112,122,149,193,222,228],"renin-angiotensin-aldosterone":[85],"system":[86],"inhibitors":[87],"previously":[89],"been":[90],"deemed":[91],"\"less":[92],"effective,\"":[93],"based":[94],"on":[95],"partially":[96],"overlapping":[97],"mechanisms":[98],"action":[100],"limited":[102],"trial":[104,132,179],"evidence.":[105],"Nebivolol":[106],"vasodilating":[109],"\u03b21-selective":[110],"blocker":[111],"\u03b23-":[113],"adrenoceptor":[114],"agonist;":[115],"\u03b23-adrenoceptor":[116],"activation":[117],"increases":[118],"nitric":[119],"oxide":[120],"concentrations":[121],"thus":[123],"explains":[124],"vasodilatory":[126],"effect.":[127],"A":[128],"recent":[129],"8-week":[130],"randomized":[131],"(N=4,161)":[133],"individuals":[135],"stage":[137],"1-2":[138],"hypertension":[139],"demonstrated":[140,181],"single-pill":[142],"fixed":[143],"dose":[144,199],"(FDC)":[146],"nebivolol":[148,217],"valsartan,":[150],"an":[151,174],"angiotensin":[152],"II":[153],"subtype":[154],"1":[155],"receptor":[156],"blocker,":[157],"more":[159,205],"effective":[160],"reducing":[162],"than":[165,206],"corresponding":[167],"monotherapies,":[168],"comparable":[170],"tolerability.":[171],"In":[172],"addition,":[173],"ABPM-biomarkers":[175],"substudy":[176],"(n=805)":[180],"FDC":[184],"prevented":[185],"valsartan-induced":[187],"increase":[188],"plasma":[190,201],"renin":[191],"activity,":[192],"nebivolol/valsartan":[196],"20/320":[197],"mg/day":[198],"reduced":[200],"aldosterone":[202],"concentration":[203],"significantly":[204],"valsartan":[207],"320":[208],"mg/day.":[209],"This":[210],"article":[211],"will":[212,229],"describe":[213],"properties":[215],"make":[219],"it":[220,224],"unique":[221],"separate":[223],"other":[226],"\u03b2-blockers,":[227],"further":[230],"support":[231],"pharmacological":[233],"advantages":[234],"this":[236],"particular":[237],"combination.":[238]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}